URGENT: The COVID-19 epidemic is severely impacting the progress of ALS research at the ALS Therapy Development Institute. If you are able to give, will you please provide an immediate gift to fund our lab?

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Friday, July 24, 2020
ASO Therapy: A Promising New Treatment, for Some – But Not All – ALS-Causing Genetic Mutations
Antisense Oligonucleotides, or ASOs, are small single-stranded molecules of DNA with a great deal of potential to help patients with genetic disorders like ALS, commonly known as Lou Gehrig’s disease.
read more
Friday, July 17, 2020
Drugs ALS TDI Has Validated, Part 2: AP-101
At the ALS Therapy Development Institute (ALS TDI), our goal is to make sure that effective treatments for ALS make it from the lab to the clinic – whether they originated from our research or some else’s.
read more
Thursday, July 9, 2020
Drugs ALS TDI Has Validated, Part 1: Copper ATSM
While our major focus is on the invention of completely new ALS treatments, we also allocate some time and resources toward investigating the validity of promising results found in experiments by other researchers and companies.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Friday, July 31, 2020
The Ales for ALS™ Brewfest Goes Virtual
On August 22, beer makers across the country will come together to put on a Virtual Brewfest for ALS
read more
Friday, July 24, 2020
ASO Therapy: A Promising New Treatment, for Some – But Not All – ALS-Causing Genetic Mutations
Antisense Oligonucleotides, or ASOs, are small single-stranded molecules of DNA with a great deal of potential to help patients with genetic disorders like ALS, commonly known as Lou Gehrig’s disease.
read more
Friday, July 17, 2020
Drugs ALS TDI Has Validated, Part 2: AP-101
At the ALS Therapy Development Institute (ALS TDI), our goal is to make sure that effective treatments for ALS make it from the lab to the clinic – whether they originated from our research or some else’s.
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Monday, April 27, 2020
Giving Tuesday Now with ALS TDI
#GivingTuesdayNow is scheduled to take place Tuesday, May 5, 2020.
read more
Monday, March 16, 2020
ALS TDI’s Plan to Continue Operations During the Ongoing COVID-19 Pandemic
Here at the ALS Therapy Development Institute we’re taking the novel coronavirus COVID-19 extremely seriously. We're taking precautions, but our ALS research will NOT stop.
read more
Tuesday, February 25, 2020
ALS TDI Featured on TODAY Segment Highlighting Project Euphonia
On Wednesday, February 19, the TODAY Show featured a special segment with Natalie Morales that focused on Project Euphonia and the partnership between ALS TDI and Google.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.